Quantcast
Last updated on April 21, 2014 at 10:19 EDT

Latest Transplantation medicine Stories

2013-11-19 16:26:00

Senate Bill 850 reported out of Senate Judiciary Committee HARRISBURG, Pa., Nov. 19, 2013 /PRNewswire/ -- "The Donate Life PA Act" (Senate Bill 850/ House Bill 30) was reported out of the Senate Judiciary Committee today and now moves to the full State Senate. The bill includes provisions to educate students in medical and nursing schools, high schools and colleges to create more awareness about organ donation, reinforces that organ transplantation is a priority over other uses of...

2013-11-19 08:27:29

- Results published in Clinical Cancer Research - JERUSALEM, Nov. 19, 2013 /PRNewswire/ -- BioLineRx (NASDAQ: BLRX; TASE: BLRX), a biopharmaceutical development company, announced today the publication of results showing that BL-8040 (formerly known as BKT-140) enables the efficient mobilization of stem cells from the bone marrow into the peripheral blood, thus facilitating autologous stem cell transplantation in multiple myeloma patients. The research was published in the journal,...

2013-11-18 04:22:16

AMSTERDAM, The Netherlands, November 18, 2013 /PRNewswire/ -- ~ 6 month follow-up data expected in H1 2014 ~ Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing treatments for blood cancers, today announces the successful Phase II enrollment of approximately ten patients of whom the majority have already been transplanted and received ATIR(TM). Kiadis Pharma's lead program, ATIR(TM), is a cell-based product designed to enable...

Study Finds Donor Age Not A Factor In Most Corneal Transplants
2013-11-15 14:02:15

NIH/National Eye Institute Ten years after a transplant, a cornea from a 71-year-old donor is likely to remain as healthy as a cornea from a donor half that age, according to a study funded by the National Institutes of Health. Corneas from donors over age 71 perform slightly less well, but still remain healthy for the majority of transplant recipients after 10 years, the study found. The Cornea Donor Study, funded by NIH's National Eye Institute (NEI), found that 10-year success rates...

2013-11-11 11:00:52

Uni of Edinburgh news release Patients with damaged organs could be helped by new treatments after scientists have discovered how tissues scar. Researchers say that the finding could pave the way for new drugs and eventually reduce the number of patients on organ transplant waiting lists. Fibrotic diseases occur in many tissues within the body – including the liver, lung or kidneys – and have a range of causes including viruses or toxins. Experts say that the main source of scar...

2013-11-08 16:24:39

Following a year of tremendous innovation and growth, AlloSource is recognized by the Colorado BioScience Association CENTENNIAL, Colo., Nov. 8, 2013 /PRNewswire-USNewswire/ -- AlloSource (allosource.org), one of the nation's largest non-profit providers of skin, bone and soft tissue allografts for use in surgical procedures and the world's largest processor of cellular bone allografts, today announced that is has been named one of the top Colorado bioscience companies of the year, as judged...

2013-11-07 08:32:26

LONDON, Nov. 7, 2013 /PRNewswire/ -- Smith & Nephew (NYSE:SNN;LSE:SN), the global medical technology business, announced the US launch of the HEALICOIL(TM)( )REGENESORB Suture Anchor at today's Arthroscopy Association of North America (AANA) Fall Course in Las Vegas. Building on the success of the innovative HEALICOIL PK design, this new suture anchor is the first device to use the company's proprietary REGENESORB material - an advanced biocomposite that has been shown in...

2013-11-04 08:26:55

Hadasit Bio-Holdings Ltd. portfolio company publishes positive results from clinical trial that shows safety and efficacy by significantly reducing the fatal effects of Graft-versus-Host Disease in bone marrow transplant recipients JERUSALEM, Nov. 4, 2013 /PRNewswire/ -- Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly traded portfolio of biotech companies, all based on intellectual property developed and owned by Hadassah University Hospital, Israel's foremost medical...

2013-11-01 08:26:48

No Better Time to Get Involved and Register as a Lifesaver NEW YORK, Nov. 1, 2013 /PRNewswire/ -- Blood cancer is the second leading cause of all cancer deaths in the United States. To lend greater awareness to a solution to this issue, Delete Blood Cancer DKMS proudly announces that November is Bone Marrow Awareness Month. Blood cancer refers to cancers that affect the blood, bone marrow and lymph nodes. Notably this will be cancer such as leukemia, myeloma and lymphoma. Many patients...

2013-10-31 11:19:00

Remissions last longer, but survival not affected, except in highest risk patients Performing early stem cell transplants in patients with aggressive non-Hodgkin's lymphoma does not improve overall survival in high-risk patients, according to a study published in the New England Journal of Medicine. But early transplantation does appear to be beneficial among a small group of patients who are at the very highest risk, the study found. Lead author is Patrick Stiff, MD, director of...


Latest Transplantation medicine Reference Libraries

Bone Marrow Transplantation (journal)
2012-06-04 20:00:41

Bone Marrow Transplantation is a peer-reviewed medical journal published monthly by Nature Publishing Group. As of May 2012, the editor-in-chief is J.M. Goldman (UK). The journal publishes high quality, original research that addresses all aspects of basic biology and clinical use of haemopoietic stem cell transplantation in humans. The broad scope of the journal thus encompasses topics such as stem cell biology, kinetics and cytokine control, transplantation immunology, HLA and matching...

More Articles (1 articles) »